[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper doesn't explicitly state a disease mechanism, however, it implies EGFR mutations drive aberrant tyrosine kinase activity in non-small cell lung cancer (NSCLC).",
        "judgment": "Yes",
        "reasoning": "Although not explicitly stated, EGFR mutations are well-established drivers of NSCLC, and the context of the study implies this relationship.",
        "next_step_or_outcome": "Proceed to Step 2"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The assays described are enzymatic activity assays designed to measure tyrosine kinase activity, which is relevant to EGFR's function in cell signaling.",
        "judgment": "Yes",
        "reasoning": "Enzymatic activity assays directly assess the proteinâ€™s core function, which is relevant to understanding the disease progression driven by EGFR mutations.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays.",
        "extracted_paper_info": "The description of the assays indicates normal and null controls were used. It states that replicates were performed.",
        "judgment": "Yes",
        "reasoning": "The inclusion of both normal/wildtype and abnormal/null controls demonstrates a general adherence to control measures, and mention of replicates suggests experimental repetition.",
        "next_step_or_outcome": "Proceed to Step 3c"
      },
      {
        "step_name": "Step 3c: Variant Controls (if basic controls/replicates were sufficient in 3a).",
        "extracted_paper_info": "No known pathogenic/benign controls are specifically mentioned.",
        "judgment": "No",
        "reasoning": "The study doesn't describe using known pathogenic or benign EGFR variants as controls for comparison.",
        "next_step_or_outcome": "Proceed to Sub-step 4b"
      },
      {
        "step_name": "Sub-step 4b: No OddsPath Calculation (if statistical analyses were insufficient).",
        "extracted_paper_info": "N/A",
        "judgment": "N/A",
        "reasoning": "N/A",
        "next_step_or_outcome": "Proceed to the overall conclusion"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "Max PS3_supporting"
    },
    "overall_conclusion": "Given the lack of documented pathogenic or benign variant controls, this functional data provides supporting, not definitive, evidence for the pathogenicity of the EGFR L858R mutation. The presence of controls and replicates does make it reasonably reliable, however, limiting the overall assignment of strength."
  }
]